MARATTO

article · British Journal of Radiology

Clinical value of 18F-PSMA-1007 PET/MRI in primary staging of patients with intermediate- to high-risk prostate cancer

20244 citationsOpen accessZagazig University

Abstract

18F-PSMA-1007 PET/MRI could have high diagnostic accuracy as shown in the current study for staging HRPCa patients that is crucial for treatment selection. We think that our study will contribute to the body of knowledge and improve the literature surrounding the clinical uses of integrated 18F-PSMA-1007 PET/MRI.

Research topics

  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Urologic and reproductive health conditions

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1093/bjr/tqae021

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.